Global Messenger RNA Vaccines and Therapeutics Market Growth (Status and Outlook) 2026-2032
The global Messenger RNA Vaccines and Therapeutics market size is predicted to grow from US$ 14620 million in 2025 to US$ 34010 million in 2032; it is expected to grow at a CAGR of 13.1% from 2026 to 2032.
An mRNA vaccine is a vaccine that uses a molecular copy of messenger RNA to generate an immune response. [1] Such vaccines deliver antigen-coding mRNA molecules into immune cells, which use the designed mRNA as a template to build foreign proteins normally produced by pathogens such as viruses or cancer cells. These protein molecules stimulate an adaptive immune response, teaching the body to recognize and destroy the corresponding pathogen or cancer cell. mRNA is composed of RNA encapsulated in lipid nanoparticles, which protect the RNA strand and facilitate its uptake into cells. Reactogenicity, the propensity of the vaccine to produce adverse reactions, was similar to that of traditional non-RNA vaccines. People prone to autoimmune reactions may experience adverse reactions to messenger RNA vaccines. Compared with traditional vaccines, mRNA vaccines have the advantages of being easy to design, fast in production, low in cost, capable of inducing cellular and humoral immunity, and not interacting with genomic DNA.
United States market for Messenger RNA Vaccines and Therapeutics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Messenger RNA Vaccines and Therapeutics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Messenger RNA Vaccines and Therapeutics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Messenger RNA Vaccines and Therapeutics players cover BioNTech, Moderna, CureVac, Pfizer, Glaxo Smith Kline's, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Messenger RNA Vaccines and Therapeutics Industry Forecast? looks at past sales and reviews total world Messenger RNA Vaccines and Therapeutics sales in 2025, providing a comprehensive analysis by region and market sector of projected Messenger RNA Vaccines and Therapeutics sales for 2026 through 2032. With Messenger RNA Vaccines and Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Messenger RNA Vaccines and Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Messenger RNA Vaccines and Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Messenger RNA Vaccines and Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Messenger RNA Vaccines and Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Messenger RNA Vaccines and Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Messenger RNA Vaccines and Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Messenger RNA Vaccines and Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
An mRNA vaccine is a vaccine that uses a molecular copy of messenger RNA to generate an immune response. [1] Such vaccines deliver antigen-coding mRNA molecules into immune cells, which use the designed mRNA as a template to build foreign proteins normally produced by pathogens such as viruses or cancer cells. These protein molecules stimulate an adaptive immune response, teaching the body to recognize and destroy the corresponding pathogen or cancer cell. mRNA is composed of RNA encapsulated in lipid nanoparticles, which protect the RNA strand and facilitate its uptake into cells. Reactogenicity, the propensity of the vaccine to produce adverse reactions, was similar to that of traditional non-RNA vaccines. People prone to autoimmune reactions may experience adverse reactions to messenger RNA vaccines. Compared with traditional vaccines, mRNA vaccines have the advantages of being easy to design, fast in production, low in cost, capable of inducing cellular and humoral immunity, and not interacting with genomic DNA.
United States market for Messenger RNA Vaccines and Therapeutics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Messenger RNA Vaccines and Therapeutics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Messenger RNA Vaccines and Therapeutics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Messenger RNA Vaccines and Therapeutics players cover BioNTech, Moderna, CureVac, Pfizer, Glaxo Smith Kline's, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Messenger RNA Vaccines and Therapeutics Industry Forecast? looks at past sales and reviews total world Messenger RNA Vaccines and Therapeutics sales in 2025, providing a comprehensive analysis by region and market sector of projected Messenger RNA Vaccines and Therapeutics sales for 2026 through 2032. With Messenger RNA Vaccines and Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Messenger RNA Vaccines and Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Messenger RNA Vaccines and Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Messenger RNA Vaccines and Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Messenger RNA Vaccines and Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Messenger RNA Vaccines and Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Messenger RNA Vaccines and Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Messenger RNA Vaccines and Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Self-amplifying
- Conventional Non-amplifying
- Cancer
- Infectious Diseases
- Autoimmune Diseases
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BioNTech
- Moderna
- CureVac
- Pfizer
- Glaxo Smith Kline's
- Daiichi Sankyo Company
- Intellia Therapeutics
- Arcturus Therapeutics
- Emmy Vaccine
- CSPC
- CanSino
- Fosun Pharma
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Messenger RNA Vaccines and Therapeutics Market Size (2021-2032)
2.1.2 Messenger RNA Vaccines and Therapeutics Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Messenger RNA Vaccines and Therapeutics by Country/Region (2021, 2025 & 2032)
2.2 Messenger RNA Vaccines and Therapeutics Segment by Type
2.2.1 Self-amplifying
2.2.2 Conventional Non-amplifying
2.2.3 Messenger RNA Vaccines and Therapeutics Market Size by Type
2.2.3.1 Messenger RNA Vaccines and Therapeutics Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Messenger RNA Vaccines and Therapeutics Market Size Market Share by Type (2021-2026)
2.3 Messenger RNA Vaccines and Therapeutics Segment by Application
2.3.1 Cancer
2.3.2 Infectious Diseases
2.3.3 Autoimmune Diseases
2.3.4 Others
2.3.5 Messenger RNA Vaccines and Therapeutics Market Size by Application
2.3.5.1 Messenger RNA Vaccines and Therapeutics Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Messenger RNA Vaccines and Therapeutics Market Size Market Share by Application (2021-2026)
3 MESSENGER RNA VACCINES AND THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Messenger RNA Vaccines and Therapeutics Market Size Market Share by Player
3.1.1 Global Messenger RNA Vaccines and Therapeutics Revenue by Player (2021-2026)
3.1.2 Global Messenger RNA Vaccines and Therapeutics Revenue Market Share by Player (2021-2026)
3.2 Global Messenger RNA Vaccines and Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MESSENGER RNA VACCINES AND THERAPEUTICS BY REGION
4.1 Messenger RNA Vaccines and Therapeutics Market Size by Region (2021-2026)
4.2 Global Messenger RNA Vaccines and Therapeutics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Messenger RNA Vaccines and Therapeutics Market Size Growth (2021-2026)
4.4 APAC Messenger RNA Vaccines and Therapeutics Market Size Growth (2021-2026)
4.5 Europe Messenger RNA Vaccines and Therapeutics Market Size Growth (2021-2026)
4.6 Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Messenger RNA Vaccines and Therapeutics Market Size by Country (2021-2026)
5.2 Americas Messenger RNA Vaccines and Therapeutics Market Size by Type (2021-2026)
5.3 Americas Messenger RNA Vaccines and Therapeutics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Messenger RNA Vaccines and Therapeutics Market Size by Region (2021-2026)
6.2 APAC Messenger RNA Vaccines and Therapeutics Market Size by Type (2021-2026)
6.3 APAC Messenger RNA Vaccines and Therapeutics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Messenger RNA Vaccines and Therapeutics Market Size by Country (2021-2026)
7.2 Europe Messenger RNA Vaccines and Therapeutics Market Size by Type (2021-2026)
7.3 Europe Messenger RNA Vaccines and Therapeutics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Messenger RNA Vaccines and Therapeutics by Region (2021-2026)
8.2 Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size by Type (2021-2026)
8.3 Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MESSENGER RNA VACCINES AND THERAPEUTICS MARKET FORECAST
10.1 Global Messenger RNA Vaccines and Therapeutics Forecast by Region (2027-2032)
10.1.1 Global Messenger RNA Vaccines and Therapeutics Forecast by Region (2027-2032)
10.1.2 Americas Messenger RNA Vaccines and Therapeutics Forecast
10.1.3 APAC Messenger RNA Vaccines and Therapeutics Forecast
10.1.4 Europe Messenger RNA Vaccines and Therapeutics Forecast
10.1.5 Middle East & Africa Messenger RNA Vaccines and Therapeutics Forecast
10.2 Americas Messenger RNA Vaccines and Therapeutics Forecast by Country (2027-2032)
10.2.1 United States Market Messenger RNA Vaccines and Therapeutics Forecast
10.2.2 Canada Market Messenger RNA Vaccines and Therapeutics Forecast
10.2.3 Mexico Market Messenger RNA Vaccines and Therapeutics Forecast
10.2.4 Brazil Market Messenger RNA Vaccines and Therapeutics Forecast
10.3 APAC Messenger RNA Vaccines and Therapeutics Forecast by Region (2027-2032)
10.3.1 China Messenger RNA Vaccines and Therapeutics Market Forecast
10.3.2 Japan Market Messenger RNA Vaccines and Therapeutics Forecast
10.3.3 Korea Market Messenger RNA Vaccines and Therapeutics Forecast
10.3.4 Southeast Asia Market Messenger RNA Vaccines and Therapeutics Forecast
10.3.5 India Market Messenger RNA Vaccines and Therapeutics Forecast
10.3.6 Australia Market Messenger RNA Vaccines and Therapeutics Forecast
10.4 Europe Messenger RNA Vaccines and Therapeutics Forecast by Country (2027-2032)
10.4.1 Germany Market Messenger RNA Vaccines and Therapeutics Forecast
10.4.2 France Market Messenger RNA Vaccines and Therapeutics Forecast
10.4.3 UK Market Messenger RNA Vaccines and Therapeutics Forecast
10.4.4 Italy Market Messenger RNA Vaccines and Therapeutics Forecast
10.4.5 Russia Market Messenger RNA Vaccines and Therapeutics Forecast
10.5 Middle East & Africa Messenger RNA Vaccines and Therapeutics Forecast by Region (2027-2032)
10.5.1 Egypt Market Messenger RNA Vaccines and Therapeutics Forecast
10.5.2 South Africa Market Messenger RNA Vaccines and Therapeutics Forecast
10.5.3 Israel Market Messenger RNA Vaccines and Therapeutics Forecast
10.5.4 Turkey Market Messenger RNA Vaccines and Therapeutics Forecast
10.6 Global Messenger RNA Vaccines and Therapeutics Forecast by Type (2027-2032)
10.7 Global Messenger RNA Vaccines and Therapeutics Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Messenger RNA Vaccines and Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 BioNTech
11.1.1 BioNTech Company Information
11.1.2 BioNTech Messenger RNA Vaccines and Therapeutics Product Offered
11.1.3 BioNTech Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 BioNTech Main Business Overview
11.1.5 BioNTech Latest Developments
11.2 Moderna
11.2.1 Moderna Company Information
11.2.2 Moderna Messenger RNA Vaccines and Therapeutics Product Offered
11.2.3 Moderna Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Moderna Main Business Overview
11.2.5 Moderna Latest Developments
11.3 CureVac
11.3.1 CureVac Company Information
11.3.2 CureVac Messenger RNA Vaccines and Therapeutics Product Offered
11.3.3 CureVac Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 CureVac Main Business Overview
11.3.5 CureVac Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Messenger RNA Vaccines and Therapeutics Product Offered
11.4.3 Pfizer Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 Glaxo Smith Kline's
11.5.1 Glaxo Smith Kline's Company Information
11.5.2 Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Product Offered
11.5.3 Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Glaxo Smith Kline's Main Business Overview
11.5.5 Glaxo Smith Kline's Latest Developments
11.6 Daiichi Sankyo Company
11.6.1 Daiichi Sankyo Company Company Information
11.6.2 Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Product Offered
11.6.3 Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Daiichi Sankyo Company Main Business Overview
11.6.5 Daiichi Sankyo Company Latest Developments
11.7 Intellia Therapeutics
11.7.1 Intellia Therapeutics Company Information
11.7.2 Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Product Offered
11.7.3 Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Intellia Therapeutics Main Business Overview
11.7.5 Intellia Therapeutics Latest Developments
11.8 Arcturus Therapeutics
11.8.1 Arcturus Therapeutics Company Information
11.8.2 Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Product Offered
11.8.3 Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Arcturus Therapeutics Main Business Overview
11.8.5 Arcturus Therapeutics Latest Developments
11.9 Emmy Vaccine
11.9.1 Emmy Vaccine Company Information
11.9.2 Emmy Vaccine Messenger RNA Vaccines and Therapeutics Product Offered
11.9.3 Emmy Vaccine Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Emmy Vaccine Main Business Overview
11.9.5 Emmy Vaccine Latest Developments
11.10 CSPC
11.10.1 CSPC Company Information
11.10.2 CSPC Messenger RNA Vaccines and Therapeutics Product Offered
11.10.3 CSPC Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 CSPC Main Business Overview
11.10.5 CSPC Latest Developments
11.11 CanSino
11.11.1 CanSino Company Information
11.11.2 CanSino Messenger RNA Vaccines and Therapeutics Product Offered
11.11.3 CanSino Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 CanSino Main Business Overview
11.11.5 CanSino Latest Developments
11.12 Fosun Pharma
11.12.1 Fosun Pharma Company Information
11.12.2 Fosun Pharma Messenger RNA Vaccines and Therapeutics Product Offered
11.12.3 Fosun Pharma Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Fosun Pharma Main Business Overview
11.12.5 Fosun Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Messenger RNA Vaccines and Therapeutics Market Size (2021-2032)
2.1.2 Messenger RNA Vaccines and Therapeutics Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Messenger RNA Vaccines and Therapeutics by Country/Region (2021, 2025 & 2032)
2.2 Messenger RNA Vaccines and Therapeutics Segment by Type
2.2.1 Self-amplifying
2.2.2 Conventional Non-amplifying
2.2.3 Messenger RNA Vaccines and Therapeutics Market Size by Type
2.2.3.1 Messenger RNA Vaccines and Therapeutics Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Messenger RNA Vaccines and Therapeutics Market Size Market Share by Type (2021-2026)
2.3 Messenger RNA Vaccines and Therapeutics Segment by Application
2.3.1 Cancer
2.3.2 Infectious Diseases
2.3.3 Autoimmune Diseases
2.3.4 Others
2.3.5 Messenger RNA Vaccines and Therapeutics Market Size by Application
2.3.5.1 Messenger RNA Vaccines and Therapeutics Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Messenger RNA Vaccines and Therapeutics Market Size Market Share by Application (2021-2026)
3 MESSENGER RNA VACCINES AND THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Messenger RNA Vaccines and Therapeutics Market Size Market Share by Player
3.1.1 Global Messenger RNA Vaccines and Therapeutics Revenue by Player (2021-2026)
3.1.2 Global Messenger RNA Vaccines and Therapeutics Revenue Market Share by Player (2021-2026)
3.2 Global Messenger RNA Vaccines and Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MESSENGER RNA VACCINES AND THERAPEUTICS BY REGION
4.1 Messenger RNA Vaccines and Therapeutics Market Size by Region (2021-2026)
4.2 Global Messenger RNA Vaccines and Therapeutics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Messenger RNA Vaccines and Therapeutics Market Size Growth (2021-2026)
4.4 APAC Messenger RNA Vaccines and Therapeutics Market Size Growth (2021-2026)
4.5 Europe Messenger RNA Vaccines and Therapeutics Market Size Growth (2021-2026)
4.6 Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Messenger RNA Vaccines and Therapeutics Market Size by Country (2021-2026)
5.2 Americas Messenger RNA Vaccines and Therapeutics Market Size by Type (2021-2026)
5.3 Americas Messenger RNA Vaccines and Therapeutics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Messenger RNA Vaccines and Therapeutics Market Size by Region (2021-2026)
6.2 APAC Messenger RNA Vaccines and Therapeutics Market Size by Type (2021-2026)
6.3 APAC Messenger RNA Vaccines and Therapeutics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Messenger RNA Vaccines and Therapeutics Market Size by Country (2021-2026)
7.2 Europe Messenger RNA Vaccines and Therapeutics Market Size by Type (2021-2026)
7.3 Europe Messenger RNA Vaccines and Therapeutics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Messenger RNA Vaccines and Therapeutics by Region (2021-2026)
8.2 Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size by Type (2021-2026)
8.3 Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MESSENGER RNA VACCINES AND THERAPEUTICS MARKET FORECAST
10.1 Global Messenger RNA Vaccines and Therapeutics Forecast by Region (2027-2032)
10.1.1 Global Messenger RNA Vaccines and Therapeutics Forecast by Region (2027-2032)
10.1.2 Americas Messenger RNA Vaccines and Therapeutics Forecast
10.1.3 APAC Messenger RNA Vaccines and Therapeutics Forecast
10.1.4 Europe Messenger RNA Vaccines and Therapeutics Forecast
10.1.5 Middle East & Africa Messenger RNA Vaccines and Therapeutics Forecast
10.2 Americas Messenger RNA Vaccines and Therapeutics Forecast by Country (2027-2032)
10.2.1 United States Market Messenger RNA Vaccines and Therapeutics Forecast
10.2.2 Canada Market Messenger RNA Vaccines and Therapeutics Forecast
10.2.3 Mexico Market Messenger RNA Vaccines and Therapeutics Forecast
10.2.4 Brazil Market Messenger RNA Vaccines and Therapeutics Forecast
10.3 APAC Messenger RNA Vaccines and Therapeutics Forecast by Region (2027-2032)
10.3.1 China Messenger RNA Vaccines and Therapeutics Market Forecast
10.3.2 Japan Market Messenger RNA Vaccines and Therapeutics Forecast
10.3.3 Korea Market Messenger RNA Vaccines and Therapeutics Forecast
10.3.4 Southeast Asia Market Messenger RNA Vaccines and Therapeutics Forecast
10.3.5 India Market Messenger RNA Vaccines and Therapeutics Forecast
10.3.6 Australia Market Messenger RNA Vaccines and Therapeutics Forecast
10.4 Europe Messenger RNA Vaccines and Therapeutics Forecast by Country (2027-2032)
10.4.1 Germany Market Messenger RNA Vaccines and Therapeutics Forecast
10.4.2 France Market Messenger RNA Vaccines and Therapeutics Forecast
10.4.3 UK Market Messenger RNA Vaccines and Therapeutics Forecast
10.4.4 Italy Market Messenger RNA Vaccines and Therapeutics Forecast
10.4.5 Russia Market Messenger RNA Vaccines and Therapeutics Forecast
10.5 Middle East & Africa Messenger RNA Vaccines and Therapeutics Forecast by Region (2027-2032)
10.5.1 Egypt Market Messenger RNA Vaccines and Therapeutics Forecast
10.5.2 South Africa Market Messenger RNA Vaccines and Therapeutics Forecast
10.5.3 Israel Market Messenger RNA Vaccines and Therapeutics Forecast
10.5.4 Turkey Market Messenger RNA Vaccines and Therapeutics Forecast
10.6 Global Messenger RNA Vaccines and Therapeutics Forecast by Type (2027-2032)
10.7 Global Messenger RNA Vaccines and Therapeutics Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Messenger RNA Vaccines and Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 BioNTech
11.1.1 BioNTech Company Information
11.1.2 BioNTech Messenger RNA Vaccines and Therapeutics Product Offered
11.1.3 BioNTech Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 BioNTech Main Business Overview
11.1.5 BioNTech Latest Developments
11.2 Moderna
11.2.1 Moderna Company Information
11.2.2 Moderna Messenger RNA Vaccines and Therapeutics Product Offered
11.2.3 Moderna Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Moderna Main Business Overview
11.2.5 Moderna Latest Developments
11.3 CureVac
11.3.1 CureVac Company Information
11.3.2 CureVac Messenger RNA Vaccines and Therapeutics Product Offered
11.3.3 CureVac Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 CureVac Main Business Overview
11.3.5 CureVac Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Messenger RNA Vaccines and Therapeutics Product Offered
11.4.3 Pfizer Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 Glaxo Smith Kline's
11.5.1 Glaxo Smith Kline's Company Information
11.5.2 Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Product Offered
11.5.3 Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Glaxo Smith Kline's Main Business Overview
11.5.5 Glaxo Smith Kline's Latest Developments
11.6 Daiichi Sankyo Company
11.6.1 Daiichi Sankyo Company Company Information
11.6.2 Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Product Offered
11.6.3 Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Daiichi Sankyo Company Main Business Overview
11.6.5 Daiichi Sankyo Company Latest Developments
11.7 Intellia Therapeutics
11.7.1 Intellia Therapeutics Company Information
11.7.2 Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Product Offered
11.7.3 Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Intellia Therapeutics Main Business Overview
11.7.5 Intellia Therapeutics Latest Developments
11.8 Arcturus Therapeutics
11.8.1 Arcturus Therapeutics Company Information
11.8.2 Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Product Offered
11.8.3 Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Arcturus Therapeutics Main Business Overview
11.8.5 Arcturus Therapeutics Latest Developments
11.9 Emmy Vaccine
11.9.1 Emmy Vaccine Company Information
11.9.2 Emmy Vaccine Messenger RNA Vaccines and Therapeutics Product Offered
11.9.3 Emmy Vaccine Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Emmy Vaccine Main Business Overview
11.9.5 Emmy Vaccine Latest Developments
11.10 CSPC
11.10.1 CSPC Company Information
11.10.2 CSPC Messenger RNA Vaccines and Therapeutics Product Offered
11.10.3 CSPC Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 CSPC Main Business Overview
11.10.5 CSPC Latest Developments
11.11 CanSino
11.11.1 CanSino Company Information
11.11.2 CanSino Messenger RNA Vaccines and Therapeutics Product Offered
11.11.3 CanSino Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 CanSino Main Business Overview
11.11.5 CanSino Latest Developments
11.12 Fosun Pharma
11.12.1 Fosun Pharma Company Information
11.12.2 Fosun Pharma Messenger RNA Vaccines and Therapeutics Product Offered
11.12.3 Fosun Pharma Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Fosun Pharma Main Business Overview
11.12.5 Fosun Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Messenger RNA Vaccines and Therapeutics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Messenger RNA Vaccines and Therapeutics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Self-amplifying
Table 4. Major Players of Conventional Non-amplifying
Table 5. Messenger RNA Vaccines and Therapeutics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Messenger RNA Vaccines and Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Messenger RNA Vaccines and Therapeutics Market Size Market Share by Type (2021-2026)
Table 8. Messenger RNA Vaccines and Therapeutics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Messenger RNA Vaccines and Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Messenger RNA Vaccines and Therapeutics Market Size Market Share by Application (2021-2026)
Table 11. Global Messenger RNA Vaccines and Therapeutics Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Messenger RNA Vaccines and Therapeutics Revenue Market Share by Player (2021-2026)
Table 13. Messenger RNA Vaccines and Therapeutics Key Players Head office and Products Offered
Table 14. Messenger RNA Vaccines and Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Messenger RNA Vaccines and Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Messenger RNA Vaccines and Therapeutics Market Size Market Share by Region (2021-2026)
Table 19. Global Messenger RNA Vaccines and Therapeutics Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Messenger RNA Vaccines and Therapeutics Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Messenger RNA Vaccines and Therapeutics Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Messenger RNA Vaccines and Therapeutics Market Size Market Share by Country (2021-2026)
Table 23. Americas Messenger RNA Vaccines and Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Messenger RNA Vaccines and Therapeutics Market Size Market Share by Type (2021-2026)
Table 25. Americas Messenger RNA Vaccines and Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Messenger RNA Vaccines and Therapeutics Market Size Market Share by Application (2021-2026)
Table 27. APAC Messenger RNA Vaccines and Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Messenger RNA Vaccines and Therapeutics Market Size Market Share by Region (2021-2026)
Table 29. APAC Messenger RNA Vaccines and Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Messenger RNA Vaccines and Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Messenger RNA Vaccines and Therapeutics Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Messenger RNA Vaccines and Therapeutics Market Size Market Share by Country (2021-2026)
Table 33. Europe Messenger RNA Vaccines and Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Messenger RNA Vaccines and Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Messenger RNA Vaccines and Therapeutics
Table 39. Key Market Challenges & Risks of Messenger RNA Vaccines and Therapeutics
Table 40. Key Industry Trends of Messenger RNA Vaccines and Therapeutics
Table 41. Global Messenger RNA Vaccines and Therapeutics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Messenger RNA Vaccines and Therapeutics Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Messenger RNA Vaccines and Therapeutics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Messenger RNA Vaccines and Therapeutics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. BioNTech Details, Company Type, Messenger RNA Vaccines and Therapeutics Area Served and Its Competitors
Table 46. BioNTech Messenger RNA Vaccines and Therapeutics Product Offered
Table 47. BioNTech Messenger RNA Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. BioNTech Main Business
Table 49. BioNTech Latest Developments
Table 50. Moderna Details, Company Type, Messenger RNA Vaccines and Therapeutics Area Served and Its Competitors
Table 51. Moderna Messenger RNA Vaccines and Therapeutics Product Offered
Table 52. Moderna Messenger RNA Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Moderna Main Business
Table 54. Moderna Latest Developments
Table 55. CureVac Details, Company Type, Messenger RNA Vaccines and Therapeutics Area Served and Its Competitors
Table 56. CureVac Messenger RNA Vaccines and Therapeutics Product Offered
Table 57. CureVac Messenger RNA Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. CureVac Main Business
Table 59. CureVac Latest Developments
Table 60. Pfizer Details, Company Type, Messenger RNA Vaccines and Therapeutics Area Served and Its Competitors
Table 61. Pfizer Messenger RNA Vaccines and Therapeutics Product Offered
Table 62. Pfizer Messenger RNA Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Pfizer Main Business
Table 64. Pfizer Latest Developments
Table 65. Glaxo Smith Kline's Details, Company Type, Messenger RNA Vaccines and Therapeutics Area Served and Its Competitors
Table 66. Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Product Offered
Table 67. Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Glaxo Smith Kline's Main Business
Table 69. Glaxo Smith Kline's Latest Developments
Table 70. Daiichi Sankyo Company Details, Company Type, Messenger RNA Vaccines and Therapeutics Area Served and Its Competitors
Table 71. Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Product Offered
Table 72. Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Daiichi Sankyo Company Main Business
Table 74. Daiichi Sankyo Company Latest Developments
Table 75. Intellia Therapeutics Details, Company Type, Messenger RNA Vaccines and Therapeutics Area Served and Its Competitors
Table 76. Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Product Offered
Table 77. Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Intellia Therapeutics Main Business
Table 79. Intellia Therapeutics Latest Developments
Table 80. Arcturus Therapeutics Details, Company Type, Messenger RNA Vaccines and Therapeutics Area Served and Its Competitors
Table 81. Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Product Offered
Table 82. Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Arcturus Therapeutics Main Business
Table 84. Arcturus Therapeutics Latest Developments
Table 85. Emmy Vaccine Details, Company Type, Messenger RNA Vaccines and Therapeutics Area Served and Its Competitors
Table 86. Emmy Vaccine Messenger RNA Vaccines and Therapeutics Product Offered
Table 87. Emmy Vaccine Messenger RNA Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Emmy Vaccine Main Business
Table 89. Emmy Vaccine Latest Developments
Table 90. CSPC Details, Company Type, Messenger RNA Vaccines and Therapeutics Area Served and Its Competitors
Table 91. CSPC Messenger RNA Vaccines and Therapeutics Product Offered
Table 92. CSPC Messenger RNA Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. CSPC Main Business
Table 94. CSPC Latest Developments
Table 95. CanSino Details, Company Type, Messenger RNA Vaccines and Therapeutics Area Served and Its Competitors
Table 96. CanSino Messenger RNA Vaccines and Therapeutics Product Offered
Table 97. CanSino Messenger RNA Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. CanSino Main Business
Table 99. CanSino Latest Developments
Table 100. Fosun Pharma Details, Company Type, Messenger RNA Vaccines and Therapeutics Area Served and Its Competitors
Table 101. Fosun Pharma Messenger RNA Vaccines and Therapeutics Product Offered
Table 102. Fosun Pharma Messenger RNA Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Fosun Pharma Main Business
Table 104. Fosun Pharma Latest Developments
Table 1. Messenger RNA Vaccines and Therapeutics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Messenger RNA Vaccines and Therapeutics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Self-amplifying
Table 4. Major Players of Conventional Non-amplifying
Table 5. Messenger RNA Vaccines and Therapeutics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Messenger RNA Vaccines and Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Messenger RNA Vaccines and Therapeutics Market Size Market Share by Type (2021-2026)
Table 8. Messenger RNA Vaccines and Therapeutics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Messenger RNA Vaccines and Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Messenger RNA Vaccines and Therapeutics Market Size Market Share by Application (2021-2026)
Table 11. Global Messenger RNA Vaccines and Therapeutics Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Messenger RNA Vaccines and Therapeutics Revenue Market Share by Player (2021-2026)
Table 13. Messenger RNA Vaccines and Therapeutics Key Players Head office and Products Offered
Table 14. Messenger RNA Vaccines and Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Messenger RNA Vaccines and Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Messenger RNA Vaccines and Therapeutics Market Size Market Share by Region (2021-2026)
Table 19. Global Messenger RNA Vaccines and Therapeutics Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Messenger RNA Vaccines and Therapeutics Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Messenger RNA Vaccines and Therapeutics Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Messenger RNA Vaccines and Therapeutics Market Size Market Share by Country (2021-2026)
Table 23. Americas Messenger RNA Vaccines and Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Messenger RNA Vaccines and Therapeutics Market Size Market Share by Type (2021-2026)
Table 25. Americas Messenger RNA Vaccines and Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Messenger RNA Vaccines and Therapeutics Market Size Market Share by Application (2021-2026)
Table 27. APAC Messenger RNA Vaccines and Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Messenger RNA Vaccines and Therapeutics Market Size Market Share by Region (2021-2026)
Table 29. APAC Messenger RNA Vaccines and Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Messenger RNA Vaccines and Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Messenger RNA Vaccines and Therapeutics Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Messenger RNA Vaccines and Therapeutics Market Size Market Share by Country (2021-2026)
Table 33. Europe Messenger RNA Vaccines and Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Messenger RNA Vaccines and Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Messenger RNA Vaccines and Therapeutics
Table 39. Key Market Challenges & Risks of Messenger RNA Vaccines and Therapeutics
Table 40. Key Industry Trends of Messenger RNA Vaccines and Therapeutics
Table 41. Global Messenger RNA Vaccines and Therapeutics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Messenger RNA Vaccines and Therapeutics Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Messenger RNA Vaccines and Therapeutics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Messenger RNA Vaccines and Therapeutics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. BioNTech Details, Company Type, Messenger RNA Vaccines and Therapeutics Area Served and Its Competitors
Table 46. BioNTech Messenger RNA Vaccines and Therapeutics Product Offered
Table 47. BioNTech Messenger RNA Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. BioNTech Main Business
Table 49. BioNTech Latest Developments
Table 50. Moderna Details, Company Type, Messenger RNA Vaccines and Therapeutics Area Served and Its Competitors
Table 51. Moderna Messenger RNA Vaccines and Therapeutics Product Offered
Table 52. Moderna Messenger RNA Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Moderna Main Business
Table 54. Moderna Latest Developments
Table 55. CureVac Details, Company Type, Messenger RNA Vaccines and Therapeutics Area Served and Its Competitors
Table 56. CureVac Messenger RNA Vaccines and Therapeutics Product Offered
Table 57. CureVac Messenger RNA Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. CureVac Main Business
Table 59. CureVac Latest Developments
Table 60. Pfizer Details, Company Type, Messenger RNA Vaccines and Therapeutics Area Served and Its Competitors
Table 61. Pfizer Messenger RNA Vaccines and Therapeutics Product Offered
Table 62. Pfizer Messenger RNA Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Pfizer Main Business
Table 64. Pfizer Latest Developments
Table 65. Glaxo Smith Kline's Details, Company Type, Messenger RNA Vaccines and Therapeutics Area Served and Its Competitors
Table 66. Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Product Offered
Table 67. Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Glaxo Smith Kline's Main Business
Table 69. Glaxo Smith Kline's Latest Developments
Table 70. Daiichi Sankyo Company Details, Company Type, Messenger RNA Vaccines and Therapeutics Area Served and Its Competitors
Table 71. Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Product Offered
Table 72. Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Daiichi Sankyo Company Main Business
Table 74. Daiichi Sankyo Company Latest Developments
Table 75. Intellia Therapeutics Details, Company Type, Messenger RNA Vaccines and Therapeutics Area Served and Its Competitors
Table 76. Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Product Offered
Table 77. Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Intellia Therapeutics Main Business
Table 79. Intellia Therapeutics Latest Developments
Table 80. Arcturus Therapeutics Details, Company Type, Messenger RNA Vaccines and Therapeutics Area Served and Its Competitors
Table 81. Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Product Offered
Table 82. Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Arcturus Therapeutics Main Business
Table 84. Arcturus Therapeutics Latest Developments
Table 85. Emmy Vaccine Details, Company Type, Messenger RNA Vaccines and Therapeutics Area Served and Its Competitors
Table 86. Emmy Vaccine Messenger RNA Vaccines and Therapeutics Product Offered
Table 87. Emmy Vaccine Messenger RNA Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Emmy Vaccine Main Business
Table 89. Emmy Vaccine Latest Developments
Table 90. CSPC Details, Company Type, Messenger RNA Vaccines and Therapeutics Area Served and Its Competitors
Table 91. CSPC Messenger RNA Vaccines and Therapeutics Product Offered
Table 92. CSPC Messenger RNA Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. CSPC Main Business
Table 94. CSPC Latest Developments
Table 95. CanSino Details, Company Type, Messenger RNA Vaccines and Therapeutics Area Served and Its Competitors
Table 96. CanSino Messenger RNA Vaccines and Therapeutics Product Offered
Table 97. CanSino Messenger RNA Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. CanSino Main Business
Table 99. CanSino Latest Developments
Table 100. Fosun Pharma Details, Company Type, Messenger RNA Vaccines and Therapeutics Area Served and Its Competitors
Table 101. Fosun Pharma Messenger RNA Vaccines and Therapeutics Product Offered
Table 102. Fosun Pharma Messenger RNA Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Fosun Pharma Main Business
Table 104. Fosun Pharma Latest Developments
LIST OF FIGURES
Figure 1. Messenger RNA Vaccines and Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Messenger RNA Vaccines and Therapeutics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Messenger RNA Vaccines and Therapeutics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Messenger RNA Vaccines and Therapeutics Sales Market Share by Country/Region (2025)
Figure 8. Messenger RNA Vaccines and Therapeutics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Messenger RNA Vaccines and Therapeutics Market Size Market Share by Type in 2025
Figure 10. Messenger RNA Vaccines and Therapeutics in Cancer
Figure 11. Global Messenger RNA Vaccines and Therapeutics Market: Cancer (2021-2026) & ($ millions)
Figure 12. Messenger RNA Vaccines and Therapeutics in Infectious Diseases
Figure 13. Global Messenger RNA Vaccines and Therapeutics Market: Infectious Diseases (2021-2026) & ($ millions)
Figure 14. Messenger RNA Vaccines and Therapeutics in Autoimmune Diseases
Figure 15. Global Messenger RNA Vaccines and Therapeutics Market: Autoimmune Diseases (2021-2026) & ($ millions)
Figure 16. Messenger RNA Vaccines and Therapeutics in Others
Figure 17. Global Messenger RNA Vaccines and Therapeutics Market: Others (2021-2026) & ($ millions)
Figure 18. Global Messenger RNA Vaccines and Therapeutics Market Size Market Share by Application in 2025
Figure 19. Global Messenger RNA Vaccines and Therapeutics Revenue Market Share by Player in 2025
Figure 20. Global Messenger RNA Vaccines and Therapeutics Market Size Market Share by Region (2021-2026)
Figure 21. Americas Messenger RNA Vaccines and Therapeutics Market Size 2021-2026 ($ millions)
Figure 22. APAC Messenger RNA Vaccines and Therapeutics Market Size 2021-2026 ($ millions)
Figure 23. Europe Messenger RNA Vaccines and Therapeutics Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size 2021-2026 ($ millions)
Figure 25. Americas Messenger RNA Vaccines and Therapeutics Value Market Share by Country in 2025
Figure 26. United States Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Messenger RNA Vaccines and Therapeutics Market Size Market Share by Region in 2025
Figure 31. APAC Messenger RNA Vaccines and Therapeutics Market Size Market Share by Type (2021-2026)
Figure 32. APAC Messenger RNA Vaccines and Therapeutics Market Size Market Share by Application (2021-2026)
Figure 33. China Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 37. India Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Messenger RNA Vaccines and Therapeutics Market Size Market Share by Country in 2025
Figure 40. Europe Messenger RNA Vaccines and Therapeutics Market Size Market Share by Type (2021-2026)
Figure 41. Europe Messenger RNA Vaccines and Therapeutics Market Size Market Share by Application (2021-2026)
Figure 42. Germany Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 43. France Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 56. APAC Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 57. Europe Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 59. United States Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 60. Canada Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 61. Mexico Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 62. Brazil Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 63. China Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 64. Japan Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 65. Korea Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 67. India Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 68. Australia Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 69. Germany Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 70. France Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 71. UK Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 72. Italy Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 73. Russia Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 74. Egypt Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 75. South Africa Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 76. Israel Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 77. Turkey Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 78. Global Messenger RNA Vaccines and Therapeutics Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Messenger RNA Vaccines and Therapeutics Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 1. Messenger RNA Vaccines and Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Messenger RNA Vaccines and Therapeutics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Messenger RNA Vaccines and Therapeutics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Messenger RNA Vaccines and Therapeutics Sales Market Share by Country/Region (2025)
Figure 8. Messenger RNA Vaccines and Therapeutics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Messenger RNA Vaccines and Therapeutics Market Size Market Share by Type in 2025
Figure 10. Messenger RNA Vaccines and Therapeutics in Cancer
Figure 11. Global Messenger RNA Vaccines and Therapeutics Market: Cancer (2021-2026) & ($ millions)
Figure 12. Messenger RNA Vaccines and Therapeutics in Infectious Diseases
Figure 13. Global Messenger RNA Vaccines and Therapeutics Market: Infectious Diseases (2021-2026) & ($ millions)
Figure 14. Messenger RNA Vaccines and Therapeutics in Autoimmune Diseases
Figure 15. Global Messenger RNA Vaccines and Therapeutics Market: Autoimmune Diseases (2021-2026) & ($ millions)
Figure 16. Messenger RNA Vaccines and Therapeutics in Others
Figure 17. Global Messenger RNA Vaccines and Therapeutics Market: Others (2021-2026) & ($ millions)
Figure 18. Global Messenger RNA Vaccines and Therapeutics Market Size Market Share by Application in 2025
Figure 19. Global Messenger RNA Vaccines and Therapeutics Revenue Market Share by Player in 2025
Figure 20. Global Messenger RNA Vaccines and Therapeutics Market Size Market Share by Region (2021-2026)
Figure 21. Americas Messenger RNA Vaccines and Therapeutics Market Size 2021-2026 ($ millions)
Figure 22. APAC Messenger RNA Vaccines and Therapeutics Market Size 2021-2026 ($ millions)
Figure 23. Europe Messenger RNA Vaccines and Therapeutics Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size 2021-2026 ($ millions)
Figure 25. Americas Messenger RNA Vaccines and Therapeutics Value Market Share by Country in 2025
Figure 26. United States Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Messenger RNA Vaccines and Therapeutics Market Size Market Share by Region in 2025
Figure 31. APAC Messenger RNA Vaccines and Therapeutics Market Size Market Share by Type (2021-2026)
Figure 32. APAC Messenger RNA Vaccines and Therapeutics Market Size Market Share by Application (2021-2026)
Figure 33. China Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 37. India Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Messenger RNA Vaccines and Therapeutics Market Size Market Share by Country in 2025
Figure 40. Europe Messenger RNA Vaccines and Therapeutics Market Size Market Share by Type (2021-2026)
Figure 41. Europe Messenger RNA Vaccines and Therapeutics Market Size Market Share by Application (2021-2026)
Figure 42. Germany Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 43. France Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Messenger RNA Vaccines and Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 56. APAC Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 57. Europe Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 59. United States Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 60. Canada Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 61. Mexico Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 62. Brazil Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 63. China Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 64. Japan Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 65. Korea Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 67. India Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 68. Australia Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 69. Germany Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 70. France Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 71. UK Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 72. Italy Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 73. Russia Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 74. Egypt Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 75. South Africa Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 76. Israel Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 77. Turkey Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
Figure 78. Global Messenger RNA Vaccines and Therapeutics Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Messenger RNA Vaccines and Therapeutics Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Messenger RNA Vaccines and Therapeutics Market Size 2027-2032 ($ millions)
